Triphenyl Phosphate Induces Lipid Accumulation in Human Mesenchymal Stem Cells via Metabolic Stress Mechanisms
By
M. C. Gronske
W. Stutts
D. Jima
J. Palumbo
H. M. Stapleton
S. W. Kullman
June 2, 2026
Clinical Scorecard: Triphenyl Phosphate Induces Lipid Accumulation in Human Mesenchymal Stem Cells via Metabolic Stress Mechanisms
At a Glance
Category Detail
Condition Key Mechanisms Target Population Humans, particularly children and individuals exposed to environmental contaminants (specify age range if possible). Care Setting
Key Highlights
Triphenyl Phosphate (TPhP) is a prevalent organophosphate flame retardant linked to various health issues. TPhP exposure is associated with lipid accumulation in human mesenchymal stem cells. Environmental exposure to TPhP occurs through multiple routes, including diet and inhalation. TPhP functions as a PPARy agonist, promoting differentiation into adipogenic lineages. Guideline-Based Recommendations
Diagnosis
Monitor exposure levels to organophosphate esters in at-risk populations. Management
Implement strategies to reduce exposure to TPhP and similar compounds. Monitoring & Follow-up
Assess metabolic health and lipid profiles in individuals with known exposure. Risks
Potential for neurotoxicity, developmental toxicity, and metabolic disorders. Patient & Prescribing Data
Individuals exposed to environmental contaminants, particularly children.
Monitor metabolic health.
Clinical Best Practices
Educate patients about potential sources of organophosphate exposure. Encourage lifestyle modifications to mitigate obesity risk. Related Resources & Content
